The ANV S2 is an exceptionally robust, highly qualified, naval vessel installed gamma radiation monitoring system used by navies worldwide to detect the residual radiation resulting from a nuclear weapon detonation. The system monitors the radiological environment within the ship or submarine whilst providing continuous data regarding the external threat in both air and water. The ANV S2 design has been proven in a comprehensive range of environmental and other conditions against UK MOD Defense Standards.
The system’s modules are designed to:
- perform continuously with minimum maintenance.
- have excellent reliability.
An ANV S2 system can have up to seven detectors capable of measuring from natural background to full threat levels which may be experienced post nuclear weapon detonation. The detectors are sited to monitor the exposure of the crew, the airborne threat and sea water contamination. For smaller vessels and submarines, a two detector system is used providing the same comprehensive data, alarms and displays for the platform.
The ANV-S2-FV is an exceptionally robust, highly qualified, vehicle installed gamma radiation monitoring system for use in first responders applications, military personnel peace keeping operations, anti-terrorist activities and by other government specialist bodies to detect the residual radiation resulting from a nuclear weapon detonation.
Features of the system include:
- Ruggedised, reliable, small, lightweight modular system
- Fully qualified to military standards
- Up to 3 detectors, capable of aiding the location of the radiation threat, if positioned appropriately on a vehicle
- Extended detection range from background up to RADIAC levels
- No internal radioactive sources
- Low through life costs
The equipment consists of a number of fixed gamma radiation detectors mounted in strategic positions, both inside and outside the vehicle. The sensor technology employed provides a wide detection range which provides rapid automatic warning when entering a nuclear radiation environment and continues to monitor and report on-going dose and dose rate information.